Lilly partners with Nvidia on AI supercomputer to speed up drug development
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
On Oct. 28, 2025, The Louisiana Illuminator reported that when there’s an outbreak of a vaccine-preventable disease, state…
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
On Oct. 27, 2025, Qureator announced a major milestone, confirming a fundamental shift in drug development under the…
On Oct. 27, 2025, a New Hampshire man resumed dialysis after living with a gene-edited pig kidney for…
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…
As of Oct. 24, 2025, the South Carolina Department of Public Health (DPH) reported 33 cases of measles…
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
On Oct. 23, 2025, researchers at a Harvard Medical School laboratory announced they are uncertain how they will…
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
On Oct. 21, 2025, private equity firms Blackstone and TPG said they will buy medical diagnostics firm Hologic…
On Oct. 21, 2025, the Oregon Department of Agriculture has warned that as wild birds begin to migrate…
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
On Oct. 15, 2025, mRNA COVID-19 vaccination in the first trimester of pregnancy isn’t tied to an elevated…
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
On Oct. 14, 2025, Japan’s health authorities have declared an influenza epidemic, with thousands of people infected with…
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…